GFAP Mouse Monoclonal Antibody [Clone ID: OTI4D11]

CAT#: TA500338S

Anti-GFAP mouse monoclonal antibody, clone OTI4D11 (formerly 4D11)

Size: 30 ul 100 ul



  View other "OTI4D11" antibodies (6)

Need it in bulk or conjugated?
Get a free quote

参与“2024逐梦开学季·科研添动力”活动,可提供10 µL试用规格

CNY 800.00


货期*
现货

规格
    • 30 ul

经常一起买 (3)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control
    • 30 ul

CNY 300.00
CNY 1,430.00


Recombinant protein of human glial fibrillary acidic protein (GFAP), transcript variant 1, 20 µg
    • 20 ug

CNY 2,900.00
CNY 6,650.00


Transient overexpression lysate of glial fibrillary acidic protein (GFAP), transcript variant 1
    • 100 ug

CNY 3,080.00

Specifications

Product Data
Clone Name OTI4D11
Applications IF, WB
Recommend Dilution WB 1:2000, IHC: 1:50-1:150
Reactivity Human, Mouse, Rat
Host Mouse
Clonality Monoclonal
Immunogen Full-length protein expressed in 293T cell transfected with human GFAP expression vector
Formulation PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
Concentration 1 mg/ml
Purification Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
Conjugation Unconjugated
Storage Condition Store at -20°C as received.
Predicted Protein Size 49.9 kDa
Gene Name glial fibrillary acidic protein
Background This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms.
Synonyms ALXDRD
Reference Data
Protein Families ES Cell Differentiation/IPS
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Other Versions

Customer Reviews 
Loading...